Staphylococcus aureus-associated infected subclavian artery pseudoaneurysm treated with dual bare-metal stent implantation: a case report
- 1Department of Vascular Surgery, General Surgery, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University
- 2Department of Vascular Surgery, General Surgery, Qilu Hospital of Shandong University
- 3Shandong Key Laboratory of Medicine and Prevention Integration in Rheumatism and Immunity Disease, Qilu Hospital of Shandong University
Abstract
Infected subclavian artery aneurysms are exceedingly rare, life-threatening vascular lesions associated with high risks of rupture and mortality. We report a 70-year-old male presenting with intermittent hemoptysis, who was diagnosed with a pseudoaneurysm of the left subclavian artery adjacent to the dominant vertebral artery. Blood cultures confirmed methicillin-sensitive Staphylococcus aureus infection. The patient underwent endovascular repair with dual bare-metal stents to preserve vertebral artery perfusion. Hemoptysis completely resolved post-intervention. Complete thrombosis and occlusion of the aneurysm sac were achieved at the 3-month follow-up, with remarkable sac shrinkage observed at 6 months. This case suggests that dual bare-metal stents may represent a feasible potential treatment alternative for highly selected patients with infected subclavian artery aneurysms. Long-term safety and efficacy remain to be further verified. Long-term antimicrobial therapy and close surveillance remain mandatory.
Related
- Surgical repair of traumatic right subclavian artery pseudoaneurysm after war shrapnel injury: A case report
- Aortopulmonary Fistula Complicating a Ruptured Infected Proximal Descending Thoracic Aortic Pseudoaneurysm.
- Comparative outcomes of axillary, jugular, and subclavian venous access for totally implantable venous access port implantation: a 335-case single-center retrospective study.
- Feline-Derived Lactiplantibacillus plantarum-Aloe Vera Polysaccharide Hydrogel as a Topical Control Strategy for Staphylococcus pseudintermedius-Infected Wounds.
- Integration of computed tomography and endoscopic findings in identifying pseudoaneurysm rupture associated with duodenal penetration by pancreatic head cancer: A case report
BibTeX
@article{li2026staphylococcus,
title = {{Staphylococcus aureus-associated infected subclavian artery pseudoaneurysm treated with dual bare-metal stent implantation: a case report}},
author = {Ruihua Li and Shuohao Shen and Yuanbin Cao and Jianjun Jiang and Xiangjiu Ding},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = oct,
doi = {10.3389/fcvm.2026.1965965},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1965965/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Staphylococcus aureus-associated infected subclavian artery pseudoaneurysm treated with dual bare-metal stent implantation: a case report
AU - Ruihua Li
AU - Shuohao Shen
AU - Yuanbin Cao
AU - Jianjun Jiang
AU - Xiangjiu Ding
PY - 2026
DA - 2026/10/22
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1965965
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1965965/full
AB - Infected subclavian artery aneurysms are exceedingly rare, life-threatening vascular lesions associated with high risks of rupture and mortality. We report a 70-year-old male presenting with intermittent hemoptysis, who was diagnosed with a pseudoaneurysm of the left subclavian artery adjacent to the dominant vertebral artery. Blood cultures confirmed methicillin-sensitive Staphylococcus aureus infection. The patient underwent endovascular repair with dual bare-metal stents to preserve vertebral artery perfusion. Hemoptysis completely resolved post-intervention. Complete thrombosis and occlusion of the aneurysm sac were achieved at the 3-month follow-up, with remarkable sac shrinkage observed at 6 months. This case suggests that dual bare-metal stents may represent a feasible potential treatment alternative for highly selected patients with infected subclavian artery aneurysms. Long-term safety and efficacy remain to be further verified. Long-term antimicrobial therapy and close surveillance remain mandatory.
SN - 2297-055X
ER -